Results 31 to 40 of about 2,327,584 (298)

Clinical presentation of brain metastases from endometrial carcinoma: A case series

open access: yesGynecologic Oncology Reports, 2019
Brain metastases from endometrial carcinoma are rare, however they do occur, and they are associated with an especially poor prognosis. There is evidence demonstrating improved outcomes with early diagnosis and subsequent multimodal treatment. This study
Marisa R. Moroney   +2 more
doaj   +1 more source

Characterization of plasma circulating small extracellular vesicles in patients with metastatic solid tumors and newly diagnosed brain metastasis

open access: yesOncoImmunology, 2022
Nearly 40% of the advanced cancer patients will present brain metastases during the course of their disease, with a 2-year life expectancy of less than 10%.
Alberto Carretero-González   +8 more
doaj   +1 more source

BRAIN METASTASES: A REVIEW ARTICLE

open access: yes, 2023
Cerebral metastases or brain metastases (brain mets) is the most common malignant intracranial cancer among all brain tumors. Brain mets are the secondary tumors migrated from the distinct organs to brain i.e. lung, breast, melanoma and kidney.
Ali Muntazir Naqvi, Anum Zehra, Syed Aqib Ali Zaidi ,Hina Khan, Arif Ali Chishti
core   +1 more source

Serial monitoring of cerebrospinal fluid in patients with leptomeningeal metastases in lung cancer via the Ommaya reservoir as a predictive indicator of therapeutic efficacy and clinical prognosis

open access: yesnpj Precision Oncology
Leptomeningeal metastasis (LM) is a severe neurological complication in patients with lung adenocarcinoma (LUAD), typically indicating terminal stage and poor survival.
Hehui Fang   +11 more
doaj   +1 more source

Therapy of breast cancer brain metastases: challenges, emerging treatments and perspectives

open access: yesTherapeutic Advances in Medical Oncology, 2018
Brain metastases are the most common central nervous system tumors in adults, and incidence of brain metastases is increasing due to both improved diagnostic techniques (e.g.
Nuria Kotecki   +3 more
doaj   +1 more source

Chemotherapy for Spinal Cord Intramedullary Pediatric Low‐Grade Glioma—A Systematic Literature Review

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric intramedullary low‐grade gliomas (PIMLGGs) are rare neoplasms that present unique clinical and management challenges. Although surgery remains the primary tool for tissue diagnosis and decompression, complete gross‐total resection is frequently unfeasible due to the infiltrative nature of these lesions.
Olga M. Sergeenko   +5 more
wiley   +1 more source

Incidence and gender difference of brain metastases in newly diagnosed follicular thyroid cancer patients

open access: yesEuropean Thyroid Journal
Background: Population-based estimates of brain metastases in follicular thyroid cancer (FTC) patients with or without distant metastases (DMs) at diagnosis are lacking.
Ruiguo Zhang   +7 more
doaj   +1 more source

Lorlatinib‐Containing Therapy for MYCN‐Amplified, ALK‐Mutated Neuroblastoma With Bulky Leptomeningeal Relapse: A Case Report

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Central nervous system (CNS) relapse of neuroblastoma carries a poor prognosis, and craniospinal irradiation (CSI) poses substantial long‐term toxicity in young children. We report a toddler with MYCN‐amplified neuroblastoma harboring somatic ALK R1275Q who developed extensive leptomeningeal relapse with paraplegia.
Jinwoo Kim   +11 more
wiley   +1 more source

Management of breast cancer brain metastases: a practical review

open access: yes, 2017
Brain metastases are a common, and frequently challenging, clinical problem in the contemporary management of metastatic breast cancer. While the management of extracranial metastatic breast cancer is now strongly defined by tumour phenotype, this ...
Khasraw, Mustafa   +2 more
core   +2 more sources

Genetic Characterization of Brain Metastases in the Era of Targeted Therapy

open access: yesFrontiers in Oncology, 2017
In the current era of molecularly targeted therapies and precision medicine, choice of cancer treatment has been increasingly tailored according to the molecular or genomic characterization of the cancer the individual has.
Catherine H. Han   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy